BJUI Mini Reviews - Adverse events from targeted therapies in advanced renal cell carcinoma: The impact on long-term use

BERKELEY, CA (UroToday.com) - Since the introduction of targeted therapy for the treatment of advanced renal cell carcinoma (RCC) the prognosis of this condition has improved.

To read more, a FREE Urotoday registration is required. Click here to register or login above.
To read UIJ content, a separate subscription is required.
Tags:
Comments (0)
Only registered users can write comments!